Isotretinoin

Isotretinoin is not associated with an increased risk for suicide or psychiatric conditions on a population level, according to a study.

The FDA has issued a notification to isotretinoin manufacturers to modify the iPledge Risk Evaluation and Mitigation Strategy to minimize procedural burdens on prescribers, pharmacists and patients.

In this edition, dermatologists ‘uniquely positioned’ to aid human trafficking victims; FDA approves Cosentyx for hidradenitis suppurativa and more.

CHICAGO — Isotretinoin can be a helpful addition to the toolbox for seborrheic dermatitis treatment, according to a study presented at the American Society for Dermatologic Surgery Annual Meeting.

Modified 5-aminolevulinic acid photodynamic therapy was as effective as isotretinoin in the treatment of severe acne with a faster onset, according to a small study.

In new pharmacokinetic analyses, patients treated with TMB-001 0.05% ointment for congenital ichthyosis experienced minimal systemic absorption of isotretinoin or its major metabolites, Timber Pharmaceuticals announced in a press release.

While some adolescents treated with isotretinoin for moderate to severe acne vulgaris reported mood-changes, a majority experienced improvement in symptoms and completed treatment, according to a study.

Two formulations of a novel topical isotretinoin ointment formulation were associated with improvements over vehicle in patients with two types of congenital ichthyosis, according to a study.

While acne was associated with incidence of inflammatory bowel disease, two drug classes used to treat acne had no such association, according to a study.

WAILEA, Hawaii — For pediatric acne patients on isotretinoin, laboratory monitoring is still necessary, but not at the levels previously believed, according to a presentation at the Maui Derm meeting.